Cite
APA Citation
Nelander, K., Lagerstrom‐Fermer, M., Amilon, C., Michaëlsson, E., Heijer, M., Kjaer, M., Russell, M., Han, D., Lindstedt, E., Whatling, C., Gan, L., & Ericsson, H. (2021). early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction. Clinical and translational science, 14(3), 812–819. http://access.bl.uk/ark:/81055/vdc_100133390034.0x000018